Kane Biotech Valuation
| KNBIF Stock | USD 0.08 0 3.13% |
Kane Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Kane Biotech from analyzing the firm fundamentals such as Profit Margin of (1.80) %, current valuation of 12.47 M, and Return On Equity of -5.97 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Kane Biotech's price fluctuation is out of control at this time. Calculation of the real value of Kane Biotech is based on 3 months time horizon. Increasing Kane Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kane otc stock is determined by what a typical buyer is willing to pay for full or partial control of Kane Biotech. Since Kane Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kane OTC Stock. However, Kane Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0775 | Real 0.0697 | Hype 0.08 | Naive 0.0789 |
The real value of Kane OTC Stock, also known as its intrinsic value, is the underlying worth of Kane Biotech OTC Stock, which is reflected in its stock price. It is based on Kane Biotech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kane Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kane Biotech helps investors to forecast how Kane otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kane Biotech more accurately as focusing exclusively on Kane Biotech's fundamentals will not take into account other important factors: Kane Biotech Total Value Analysis
Kane Biotech is now forecasted to have takeover price of 12.47 M with market capitalization of 10.45 M, debt of 1.12 M, and cash on hands of 2.53 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kane Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.47 M | 10.45 M | 1.12 M | 2.53 M |
Kane Biotech Investor Information
About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Kane Biotech last dividend was issued on the 13th of March 2017. The entity had 1:5 split on the 13th of March 2017. Kane Biotech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Kane Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kane Biotech has an asset utilization ratio of 26.21 percent. This implies that the OTC Stock is making $0.26 for each dollar of assets. An increasing asset utilization means that Kane Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Kane Biotech Ownership Allocation
Kane Biotech maintains a total of 124.83 Million outstanding shares. Kane Biotech holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kane Biotech Profitability Analysis
The company reported the revenue of 1.61 M. Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 568.44 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kane Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kane Biotech and how it compares across the competition.
About Kane Biotech Valuation
The otc valuation mechanism determines Kane Biotech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Kane Biotech. We calculate exposure to Kane Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kane Biotech's related companies.Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.
8 Steps to conduct Kane Biotech's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Kane Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kane Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kane Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kane Biotech's revenue streams: Identify Kane Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kane Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kane Biotech's growth potential: Evaluate Kane Biotech's management, business model, and growth potential.
- Determine Kane Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kane Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Kane Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Kane Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 114.8 M | |
| Retained Earnings | -33.2 M |
Complementary Tools for Kane OTC Stock analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |